Gaucher disease in the COVID-19 pandemic environment: The good, the bad and the unknown

Mol Genet Metab. 2021 Apr;132(4):213-214. doi: 10.1016/j.ymgme.2021.02.005. Epub 2021 Feb 24.
No abstract available

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Australia / epidemiology
  • COVID-19 Drug Treatment*
  • COVID-19* / complications
  • COVID-19* / etiology
  • Enzyme Replacement Therapy
  • Gaucher Disease / therapy*
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Israel / epidemiology

Substances

  • Hydroxychloroquine